- Home
- A-Z Publications
- Current Pharmaceutical Design
- Previous Issues
- Volume 31, Issue 7, 2025
Current Pharmaceutical Design - Volume 31, Issue 7, 2025
Volume 31, Issue 7, 2025
-
-
Nano Revolution: Harnessing Nanoparticles to Combat Antibiotic-resistant Bacterial Infections
Authors: Akash Vikal, Rashmi Maurya, Preeti Patel and Balak Das KurmiNanoparticles, defined as particles ranging from 1 to 100 nanometers in size, are revolutionizing the approach to combating bacterial infections amid a backdrop of escalating antibiotic resistance. Bacterial infections remain a formidable global health challenge, causing millions of deaths annually and encompassing a spectrum from common illnesses like Strep throat to severe diseases such as tuberculosis and pneumonia Read More
-
-
-
Advancing Pharmaceutical Science with Artificial Neural Networks: A Review on Optimizing Drug Delivery Systems Formulation
Authors: Simin Salarpour, Soodeh Salarpour and Mehdi Ansari DogahehDrug Delivery Systems (DDS) have been developed to address the challenges associated with traditional drug delivery methods. These DDS aim to improve drug administration, enhance patient compliance, reduce side effects, and optimize target therapy. To achieve these goals, it is crucial to design DDS with optimal performance characteristics. The final properties of a DDS are determined by several factors that go into form Read More
-
-
-
Lipid-based Non-viral Vector: Promising Approach for Gene Delivery
Authors: Anupama Panday, Bhupendra Dixena, Nishant Jain and Akhlesh Kumar JainObjectivesThe present review aims to discuss various strategies to overcome intracellular and extracellular barriers involved in gene delivery as well as the advantages, challenges, and mechanisms of gene delivery using non-viral vectors. Additionally, patents, clinical studies, and various formulation approaches related to lipid-based carrier systems are discussed.MethodsData were searched and collected from Google Sc Read More
-
-
-
Unraveling the Core Components and Critical Targets of Houttuynia cordata Thunb. in Treating Non-small Cell Lung Cancer through Network Pharmacology and Multi-omics Analysis
Authors: Jinyan Yang, Yang Li, Yan Zhang, Ling Xu, Jiahui Wang, Feng Xing and Xinqiang SongObjectiveThis study aimed to preliminary explore the molecular mechanisms of Houttuynia cordata Thunb. (H. cordata; Saururaceae) in treating non-small cell lung cancer (NSCLC), with the goal of screening drug potential targets for clinical drug development.MethodsThis study employed a multi-omics and multi-source data integration approach to identify potential therapeutic targets of H. cordata against NSCLC from the T Read More
-
-
-
Screening of Natural Compounds as Inhibitor of Mpro SARS-CoV-2 Protein; A Molecular Dynamics Approach
BackgroundNew strains of SARS-CoV-2 are continually emerging worldwide. Recently, WHO warned of a severe new wave in Europe. Current vaccines cannot fully prevent reinfection in vaccinated individuals.AimGiven this issue, recent research focuses on new antiviral candidates with high efficacy and minimal side effects.ObjectivesScreen natural compounds as inhibitors of Mpro SARS-CoV-2 protein using molecular dy Read More
-
Volumes & issues
-
Volume 31 (2025)
-
Volume 30 (2024)
-
Volume 29 (2023)
-
Volume 28 (2022)
-
Volume 27 (2021)
-
Volume 26 (2020)
-
Volume 25 (2019)
-
Volume 24 (2018)
-
Volume 23 (2017)
-
Volume 22 (2016)
-
Volume 21 (2015)
-
Volume 20 (2014)
-
Volume 19 (2013)
-
Volume 18 (2012)
-
Volume 17 (2011)
-
Volume 16 (2010)
-
Volume 15 (2009)
-
Volume 14 (2008)
-
Volume 13 (2007)
-
Volume 12 (2006)
-
Volume 11 (2005)
-
Volume 10 (2004)
-
Volume 9 (2003)
-
Volume 8 (2002)
-
Volume 7 (2001)
-
Volume 6 (2000)
Most Read This Month
Article
content/journals/cpd
Journal
10
5
false
en
